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Abstract
We describe an analysis of genome variation in 825 Plasmodium falciparum samples from Asia
and Africa that reveals an unusual pattern of parasite population structure at the epicentre of
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artemisinin resistance in western Cambodia. Within this relatively small geographical area we
have discovered several distinct but apparently sympatric parasite subpopulations with extremely
high levels of genetic differentiation. Of particular interest are three subpopulations, all associated
with clinical resistance to artemisinin, which have skewed allele frequency spectra and remarkably
high levels of haplotype homozygosity, indicative of founder effects and recent population
expansion. We provide a catalogue of SNPs that show high levels of differentiation in the
artemisinin-resistant subpopulations, including codon variants in various transporter proteins and
DNA mismatch repair proteins. These data provide a population genetic framework for
investigating the biological origins of artemisinin resistance and for defining molecular markers to
assist its elimination.
Introduction
The malaria parasite Plasmodium falciparum has a remarkable capacity to develop
resistance to antimalarial drugs by evolutionary adaptation. For reasons that remain poorly
understood, successive global waves of antimalarial drug resistance have originated in
western Cambodia.1 The most common form of chloroquine resistance was observed there
in the late 1950’s before it spread around the world 2 and the most common forms of
clinically significant pyrimethamine resistance3 and sulfadoxine resistance4 are thought to
have originated in the same region. Clinical resistance to artemisinin and its derivatives is
now well established in the P. falciparum population of western Cambodia 5-8 and appears
to be emerging in neighbouring regions.9,10 These recent developments have grave
implications for public health, since artemisinin derivatives are the mainstay of malaria
treatment worldwide. There is an urgent need to discover the parasite genetic factors that
cause artemisinin resistance 11 and to identify effective markers to monitor its spread.12
A central question is whether the genetic epidemiology of the P. falciparum population in
Cambodia offers insights into the emergence of drug resistance, and of artemisinin
resistance in particular. To address this question, we analysed patterns of genome variation
in 825 P. falciparum samples collected at 10 locations in West Africa and South-East Asia.
These include Ghana, Mali, Burkina Faso, The Gambia, Thailand, Vietnam and 4 locations
in Cambodia (Table 1). An estimated median of 2 Gbp of sequence read data were obtained
for each sample using the Illumina Genome Analyser platform, and SNP genotype calls
were made using a well-validated set of algorithms and quality control procedures whose
development and evaluation is described in detail elsewhere.13 Here we focus on a set of
86,158 coding SNPs that could be genotyped with confidence in the majority of samples, as
detailed at http://www.malariagen.net/resource/10. For purposes of quality assurance,
733/825 (89%) of the samples analysed were independently assayed for 148 SNPs using the
Sequenom platform: the genotype calls produced by Sequenom showed 99.4% concordance
with the genotypes calls obtained from Illumina sequencing (see Supplementary Note).
Population structure
As a starting point for the analysis of population structure, we constructed a neighbour-
joining tree (see Supplementary Note) of all 825 samples based on a pairwise distance
matrix (Figure 1a). Cambodian and Vietnamese samples formed a complex branching
cluster of ancestrally related individuals, which could be clearly distinguished from Thai
samples and, to a much greater extent, from West African samples. Principal components
analysis (PCA, see Supplementary Note) revealed a surprising pattern of population
structure within the total sample set: the first principal component (PC1) separated samples
from different continents, but the second and third components (PC2 and PC3 respectively)
represented variation in western Cambodia alone (Figure 1b). Although we expected to find
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high levels of population structure in South-East Asia, consistent with relatively low levels
of malaria transmission14, the strength of population structure observed in western
Cambodia was remarkable when compared to the other populations in this sample set. To
put this in geographical context, the western Cambodian sites sampled are located up to
~200km apart, while the other South-East Asian locations were separated by up to
~1000km, and the West African locations by up to ~1,500 km (Supplementary Figure 1).
Thus the population structure observed in western Cambodia cannot be explained simply by
geographical distance. We considered the possibility that it might be an artefact of increased
variance introduced by the relatively large number of samples from Cambodia, but the
signal was found to be robust when correcting for sample size by sub-sampling
(Supplementary Figure 2).
The existence of multiple parasite subpopulations in western Cambodia became evident
when PCA was restricted to South-East Asia (Figure 1c, d). A core group of western
Cambodian samples clustered with samples from north-eastern Cambodia and Vietnam,
close to samples from Thailand, while three distinct groups of western Cambodian samples
were identified as outliers from this core group by the first, second and third principal
components, respectively. An inspection of principal components beyond PC3 did not reveal
further outlier groups. Other samples were intermediate between the core and outlier groups,
suggesting admixture between the groups. To characterise this in more detail we used a
process of chromosome painting, a probabilistic method of reconstructing the chromosomes
of each individual sample from homologous segments of DNA in samples representative of
the core group and three outlier groups (see Figure 2, Methods). This yielded a matrix of
ancestral similarity in which the three outlier clusters could be clearly distinguished from
other samples, and complex admixture patterns were apparent (Supplementary Figure 3).
Using the ancestral proportions determined by chromosome painting, each Cambodian
sample was classified as belonging to one of the following subpopulations: KH1
representing the core group that clustered with samples from neighbouring countries; KH2,
KH3 and KH4 representing the three outlier groups; and KHA representing samples with
apparently mixed ancestry, defined here as having <80% ancestral content from any one of
the main groups (Figure 3a). Using these definitions, 63 samples were classified as KH1, 55
as KH2, 23 as KH3, 17 as KH4 and 135 as KHA.
Other methods of population structure analysis corroborated these findings. A neighbour-
joining tree of Cambodian and Vietnamese samples showed clusters corresponding to KH1,
KH2, KH3 and KH4, interspersed with KHA samples (Supplementary Figure 4). When the
ADMIXTURE program was used to model the Cambodian samples as admixture of 4
putative subpopulations, there was 82% concordance between the classification of samples
by ADMIXTURE and by the chromosome painting method described above (see Methods,
Supplementary Figure 5). Both analyses confirmed that most samples from north-eastern
Cambodia and Vietnam are very similar to KH1 samples in western Cambodia. It was
evident from all methods that our classification of samples into KH1/2/3/4/A should be
regarded as a first approximation, since the population structure is clearly complex and will
require further epidemiological sampling to understand in detail.
Table 2 shows the frequency of subpopulations at different locations in Cambodia. All of the
subpopulations were present in western Cambodia, while KH1 was predominant in north-
eastern Cambodia. The samples came from four independent field studies conducted over
the past 5 years: there was clear evidence of population structure within each study, and it
was not limited to a particular site or sampling year (Supplementary Tables 1-3). The
discovery of several distinct subpopulations of P. falciparum co-existing at the same location
is unexpected, and requires a biological explanation.
Miotto et al. Page 3
Nat Genet. Author manuscript; available in PMC 2013 October 28.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Artemisinin resistance
An obvious question arising from these findings is whether different parasite subpopulations
in Cambodia have different levels of resistance to artemisinin and its derivatives. To address
this question we analysed parasite clearance rates in patients with acute falciparum malaria
following artesunate treatment.6,8 In vivo estimation of parasite clearance rate from frequent
peripheral blood parasite counts is becoming the standard method used for surveillance of
artemisinin resistance, since no laboratory method has yet been developed to correlate
reliably with clinical resistance. In vivo clearance data were available for 212 of the samples
in this study: 30 from Pailin, 47 from Tasanh, 89 from Pursat and 46 from Ratanakiri (Table
2). For each sample we calculated the parasite clearance half-life based on the slope of the
linear portion of the parasite clearance curve15. This revealed a significant prolongation of
parasite clearance half-life in the KH2, KH3 and KH4 subpopulations compared to the KH1
subpopulation (Figure 3b, c). The difference was evident from analysis of all 212
Cambodian samples, and also when restricted to the 166 samples from western Cambodia.
The median parasite clearance half-life in 35 KH2 samples (all from western Cambodia) was
6.8 hours compared to 4.1 hours in 6 KH1 samples from western Cambodia (P=2×10−4 by
Mann-Whitney test) and 2.7 hours in all 50 KH1 samples from Cambodia (P= 2 ×10−14).
More detailed results for all subpopulations are given in Table 3. KHA samples showed
wide variance in parasite clearance half-life, consistent with their genetic makeup as an
admixture of artemisinin-sensitive and artemisinin-resistant types. The long median
clearance half-life in this group is consistent with selection of recombinants with an ART-R
genetic background. However, we observed no direct correlation between admixture
proportions and parasite clearance half-life (Supplementary Figure 6), which suggests that
the acquisition of ART-R phenotypes depends on receiving a limited set of specific DNA
segments from resistant ancestors.
To put this in an epidemiological context, recent clinical studies show that parasite clearance
rates following artesunate treatment are significantly faster in north-eastern Cambodia
(Fairhurst et al., manuscript in preparation) and in Vietnam10 than in western Cambodia. It
appears likely that these geographical differences in parasite clearance rate can be largely
attributed to the predominance of KH2, KH3, KH4 and KHA in western Cambodia, whereas
KH1 predominates in north-eastern Cambodia and Vietnam.
Founder effects
A striking feature of the KH2, KH3 and KH4 subpopulations is their strong genetic
differentiation relative to KH1, and also relative to each other. This was evident from
genome-wide estimates of the fixation index (FST) between subpopulations: e.g., the
pairwise FST for KH2 vs KH4 (0.38) was considerably higher than that for Thailand vs
Ghana (0.16) (Supplementary Table 4). It was also evident from counting the number of
SNPs showing high levels of FST between subpopulations: e.g. the number of SNPs with
FST >0.5 was 11 for Thailand vs KH1, 562 for Thailand vs Ghana and 1200 for KH2 vs
KH4 (Supplementary Table 5). In summary, we found higher levels of genetic
differentiation between subpopulations within western Cambodia than between typical
parasite populations on different continents.
Several features of the KH2, KH3 and KH4 subpopulations indicate that their strong genetic
differentiation is due to founder effects. Consistent with this explanation, we observed a
marked reduction of low frequency alleles in KH2, KH3 and KH4, compared to KH1 and to
parasites from other parts of South-East Asia and West Africa (Figure 4a). When SNPs with
high levels of differentiation between subpopulations were compared to SNPs with low
levels of differentiation, both groups had a similar ratio of non-synonymous to synonymous
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polymorphisms (overall pN/pS was 2.4 for SNPs with FST <0.2, and 2.1 for SNPs with FST
>0.8; Supplementary Table 6), suggesting that differentiation is likely to have arisen from
founder effects.
As further evidence for founder effects, the KH2, KH3 and KH4 subpopulations were
observed to have markedly reduced haplotype diversity. This was evident from higher levels
of linkage disequilibrium in KH2, KH3 and KH4 compared to KH1 and other populations
(Figure 4b). The loss of haplotypic diversity was also quantified more directly, e.g. levels of
haplotype homozygosity, measured in a sliding window across the genome (see
Supplementary Note), were considerably higher for KH2, KH3 and KH4 than for KH1
(Figure 4c, Supplementary Figure 7). The level of haplotype diversity varied considerably
across the genome, and in some cases it was found that a single haplotype predominates
across a large chromosomal region, e.g. KH4 has essentially a single haplotype across most
of chromosome 9, and that KH2 has essentially a single haplotype across approximately half
of chromosome 13 (1.4-3.4Mb), in marked contrast with KH1 (Supplementary Figure 8).
An analysis of within-host diversity, quantified in terms of the FWS metric13, shows that the
vast majority of samples in KH2, KH3 and KH4 are essentially clonal, as are those in the
recombinant KHA population (Supplementary Figure 9). Although within-sample diversity
was found to be generally lower in Southeast Asian populations than in West Africa, the
artemisinin-resistant samples are clearly more likely to be clonal than those in KH1 or in
Thailand. This suggests a high level of inbreeding in the KH2/3/4 populations.
We conclude that western Cambodia is home to at least three distinct founder populations of
P. falciparum, each of which is artemisinin resistant, co-existing with a more diverse and
widely-distributed subpopulation to which they are ancestrally related (Figure 1a). Although
KH2, KH3 and KH4 populations maintain extreme genetic differentiation, analyses of
population structure and chromosome painting indicate that there is some gene flow between
these populations (Figure 2). This is most evident in KHA, which appears as a mosaic of the
other populations. This appearance might have arisen from recent admixture or from past
evolutionary events, or some combination of the two. Future studies may be able to
elucidate the evolutionary and demographic processes that underlie these observations.
Genetic markers and candidate loci
These data provide a set of genetic markers to map the geographic distribution of the
artemisinin-resistant founder populations and to monitor their spread outside western
Cambodia. Supplementary Tables 7-9 lists SNPs that differentiate the founder populations
from other populations analysed here.
To illustrate the potential utility of this dataset, it has recently been reported that low levels
of artemisinin-resistance observed in North-Western Thailand are associated with a genomic
region of low haplotype diversity on chromosome 13, around the 1.7-1.8 Mb position7. We
find that KH2 has essentially a single haplotype extending across half of chromosome 13,
from the 1.4Mb to the 3.4Mb position (Supplementary Figure 8). At position 13:2075035 we
observe a codon variant (Y175S) in an ABC transporter gene (PF13_0271) for which all
samples from West Africa carry the ancestral allele, whereas almost all KH2 samples have
the derived (non-ancestral) allele. Since this gene has been experimentally associated with
chloroquine and quinine resistance 16 and has previously been reported to lie within a
genomic region of positive selection17, it would appear to be an important candidate for
further investigation.
Supplementary Table 10 lists transporter genes that are highly differentiated in the founder
populations, as these are prime candidates for the causation of antimalarial drug
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resistance.16,18 Apart from PF13_0271, they include PFE1150w (pfmdr1, an ABC
transporter known to be associated with drug resistance), PFC0725c (a putative formate-
nitrate transporter), PFE0805w (a cation-transporting ATPase 1) and PF13_0252 (a
nucleoside transporter).
The founder populations also serve as a reservoir for a variety of known antimalarial
resistance alleles (Supplementary Table 11). In pfcrt19, almost all samples in KH2, KH3 and
KH4 have the resistant haplotype CVIET, whereas KH1 has a wider variety of
haplotypes.20,21 A comparison of pfmdr1 22-24 sequence coverage suggests that most
samples in KH4 and KH3 have higher copy numbers than those in KH1 and KH2
(Supplementary Table 12). In pfdhps 25, KH2 has a high frequency of the triple mutant
haplotype comprising K540N, A581G and A437G 26,27, whereas KH3 and KH4 have a high
frequency of the triple mutant haplotype comprising S436A, K540E and A437G28. In
pfdhfr 25,29 the codon variant I164L, which characterizes a highly resistant triple or
quadruple mutant haplotype30, is absent in KH1 and KH4, but near fixation in KH2 and at
an intermediate frequency in KH3.
It has been proposed that antimalarial resistance emerges rapidly in South-East Asia because
of the existence of hypermutable parasites, based on experimental evidence that a P.
falciparum strain originating from Indochina shows accelerated resistance to multiple
structurally unrelated drugs 31. It will therefore be of interest to researchers in this area that a
number of the most differentiated nonsynonymous SNPs in the KH2 subpopulations are
located in genes involved in DNA mismatch repair pathways (Supplementary Table 13).
These include PMS1 and MLH, the two proteins that make up MutL, a DNA mismatch
repair heterodimer that is highly conserved throughout evolution32; and UvrD, a helicase
that is critical for methyl-directed mismatch repair and interacts physically with MutL,
which loads it onto DNA.33-35 This could be highly relevant, since MutL variants in bacteria
have been shown to cause hypermutation and rapid evolution of antibiotic resistance.
However, uncertainty over the evolutionary timeline of the KH2 population means that
further studies will be needed to establish whether these parasites are indeed hypermutable.
Discussion
P. falciparum population structure is known to be related to the intensity of malaria
transmission. The parasites are transmitted to humans by Anopheles mosquitoes, and a
crucial step in this process is sexual recombination of parasites within the mosquito vector.
Previous studies have shown that higher rates of inbreeding and greater population structure
occur in regions of low transmission intensity, such as Southeast Asia, than in high
transmission regions such as West Africa.36,37
The population structure observed in Western Cambodia is unusual in several respects.
Within this relatively small geographical area we find multiple distinct, but apparently
sympatric, parasite subpopulations with exceptionally high levels of genetic differentiation.
Three of the subpopulations have skewed allele frequency spectra and remarkably high
levels of haplotype homozygosity, indicative of founder effects and recent population
expansion. These subpopulations are associated with clinical resistance to artemisinin. Two
key questions arise from these findings: what caused the founder effects and what is the
biological significance of their association with artemisinin resistance?
Here we offer a hypothesis to explain these unusual findings. Our starting assumption is that
a parasite population under drug pressure will eventually acquire a number of genetic
variants with the potential to cause drug resistance. However, the majority of such variants
will have relatively small effects when acting individually. Moreover, many potential
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resistance alleles will be associated with a biological fitness cost in the absence of the drug.
We postulate that the process of sexual recombination occasionally produces a parasite
possessing a ‘winning combination’ of alleles that jointly confer high levels of drug
resistance together with high levels of biological fitness. The inbred progeny of such a
parasite, which carry the full set of alleles required for optimum biological fitness, are at a
selective advantage compared to the rest of the parasite population. When such a parasite
outcrosses with other parasite lines, the progeny are at risk of losing the winning
combination of alleles and thereby losing biological fitness. In brief, our hypothesis is that
the founder effects observed in Western Cambodia represent recent expansion of
artemisinin-resistant parasite lines, whose biological fitness requires a particular
combination of alleles to be maintained at multiple loci across the genome.
If this hypothesis is broadly correct, it follows that multiple environmental and ecological
factors will affect the emergence and spread of artemisinin resistance. A multigenic
resistance phenotype is more likely to emerge if the individual component alleles are already
prevalent in the local parasite population, as determined by the history of previous
antimalarial drug usage. Low transmission intensity and other factors that favour inbreeding
could assist the propagation of a multigenic resistance phenotype once it has emerged. High
rates of inbreeding might also arise due to physical isolation, e.g. if a group of parasites
became isolated in a remote area of the jungle, or due to some form of reproductive
isolation, e.g. it is conceivable that different parasite subpopulations are preferentially
transmitted by different Anopheles vector species.38
These observations provide a population genetic framework for revisiting the longstanding
debate about why Western Cambodia is a global hotspot for antimalarial drug resistance.
Drug pressure was particularly high in Pailin in the late 1950s and early 1960s as a result of
mass administration of chloroquine and pyrimethamine.39,40 This may explain why these
subpopulations possess a variety of haplotypes that are highly resistant to antimalarials other
than artemisinin - in other words it is possible that we are witnessing the most recent episode
in a longer and more complex chain of events. Human demographic factors relevant to
Western Cambodia should also be considered, such as physical isolation of human
settlements due to poor road infrastructure in forested mountain areas, or to restricted human
movement in the period of Khmer Rouge resistance (1979-1998), which might have
provided a favourable environment for parasite inbreeding.
A major objective of the WHO Global Plan for Artemisinin Resistance Containment is to
stop the spread of resistant parasites.41 The discovery of multiple subpopulations of resistant
parasites, with widely different genetic characteristics, suggests that there could be multiple
forms of resistance, each of which will need to be controlled. The definition of genetic
markers for these subpopulations will assist efforts to eliminate major foci of transmission
through characterisation of their geographical distribution and the ecological niches that they
occupy. This will require the acquisition of genomic epidemiological data at a high level of
spatial and temporal resolution, and the data presented here should not be regarded as a
definitive account of the current situation, which is clearly in flux.9
Methods
Ethical Approval
All samples in this study were derived from blood samples obtained from patients with P.
falciparum malaria, collected with informed consent from the patient or a parent or guardian.
At each location, sample collection was approved by the appropriate local ethics committee;
a full list is given in the Supplementary Note.
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Clinical Phenotype Determination in Cambodian Samples
In Pursat, patients aged 10-65 years had uncomplicated malaria with a P. falciparum density
≥10,000/μl whole blood.8 Patients were treated with 4 mg/kg artesunate given orally at 0, 24
and 48 h, followed by 15 mg/kg mefloquine given orally at 72 h, and 10 mg/kg mefloquine
given orally at 96 h. During treatment, thick blood films were made from finger-prick blood
samples every 6 h until the asexual parasite density was undetectable. In Ratanakiri, patients
were aged 2-65 years and their parasite density was counted every 6 h until undetectable or
48 h elapsed, whichever occurred first. Further details can be obtained from the trial
registrations (NCT00341003 for Pursat; NCT01240603 for Ratanakiri).
In Tasanh and Pailin, two separate but coordinated studies were conducted within the
Artemisinin Resistance Confirmation, Characterisation and Containment (ARC3) multi-site
study, with harmonized methodologies. Depending on the study arm, patients recruited were
aged 18-65, presenting acute P. falciparum malaria symptoms, with a parasite density of
1000-200,000/μL. In Tasanh patients were treated with artesunate, given as a single oral
dose of 2, 4 or 6 mg/kg/day for 7 days. Parasite counts based on blood smears were taken up
to 8 times on Day 0, and then 4 times a day until 2 consecutive thick blood films were
negative for asexual parasites. Further details of the Tasanh study are given in42. In Pailin
patients were treated with artesunate in a daily dose of 6 or 8 mg/kg administered as a single
or split dose. Three day regimens were followed by a split dose of mefloquine at 72 and 96
hours. Peripheral blood parasitemia was assessed at 0, 2, 4, 6, 8, 12, and 18 hours after
enrolment and then 6 hourly until two consecutive slides were negative. More details can be
obtained from the trial registration (ISRCTN15351875).
For all sites, parasite clearance half-life estimates were computed from the frequent parasite
counts obtained during treatment. The statistical models used to estimate the parasite
clearance rate constant and lag phase duration were fitted using the Parasite Clearance
Estimator15 developed by the Worldwide Antimalarial Resistance Network (WWARN),
accessible at https://www.wwarn.org/research/parasite-clearance-estimator.
Sequencing and Genotyping
The sequencing and genotyping methods applied to the clinical samples were previously
published13 and are briefly summarized here; an extended description is provided in the
Supplementary Note. For most samples, parasitized erythrocytes were obtained directly
from the blood samples, after leukocyte depletion to remove the majority of human DNA,
without culturing. A minority of samples from Thailand and Cambodia were adapted to in
vitro culture prior to DNA extraction. Samples with >1 μg DNA and <60% human DNA
contamination were sequenced by the Illumina Genome Analyzer II, with read lengths
ranging from 37 to 105 bp. From short sequence read alignments against the P. falciparum
3D7 reference, we obtained a set of 86,158 quality-controlled SNPs which passed a series of
stringent quality filters13 (the V1.0 SNP Catalogue). Samples were genotyped at each SNP
by a single allele, based on sequencing read counts.
Allele Frequency Analysis
Allele frequencies at any given SNP in any given population were determined by analysing
all genotyped samples (i.e. samples with undetermined genotype at the SNP were excluded
from the computation). The non-reference allele frequency (NRAF) was computed as the
proportion of genotyped samples in the population whose genotype was not the reference
allele. The minor allele frequency (MAF) was computed as the proportion of genotyped
samples carrying the least common genotype in the population (i.e. MAF=NRAF if
NRAF<0.5; MAF=(1-NRAF) otherwise).
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In analyses where derived allele frequency (DAF) was used, we determined the putative
ancestral state alleles at each position by comparison of the allele in the P. falciparum 3D7
reference sequence with alleles in homologous sequences observed in P. reichenowi (Pr) as
previously described13. The putative ancestral/derived alleles at each SNP are included in
the online 86k SNP dataset. The derived allele frequency (DAF) was computed as the
proportion of genotyped samples carrying the derived allele in a population; the DAF was
undetermined at positions where the putative ancestral/derived state could not be
established.
We determined gene reading frames and exon boundaries from the PlasmoDB 5.5
annotation (www.plasmodb.org) of the 3D7 genome43. Each SNP in our 86k set was
classified as synonymous or non-synonymous according to whether an amino acid change
occurs when substituting the reference allele with the non-reference allele at that SNP in the
3D7 reference genome sequence, without any other changes.
Chromosome Painting
Chromosome painting44 is a probabilistic method of reconstructing the ancestry of
individuals in a recombinant population. While commonly used methods for discovering
population structure (such as ADMIXTURE45) tend to consider SNPs independently,
chromosome painting utilizes linkage information in the dataset in its probability
computation, based on the assumption that groups of linked alleles tend to be exchanged
together during recombination. Hence, given a set of candidate recombinant “donor”
populations, chromosome painting assigns the most probably ancestral population to a
chunk of DNA from a given individual, based on its similarity to corresponding chunks in
individuals from the donor populations (rather than perform this analysis on each SNP
independently). This results in visualizations of the recombination patterns, which assign a
colour to each donor population, and use these colours to paint each DNA chunk according
to the most probable assignment.
We performed chromosome painting using the Chromopainter software package (http://
www.maths.bris.ac.uk/~madjl/finestructure/chromopainter.html). The parameters Ne
(effective population size) and μ (global mutation rate) were estimated in Cambodian
samples by running the expectation-maximization (E-M) algorithm for 40 iterations, for
each sample and chromosome. For this analysis, a small number of samples were excluded
to ensure that no two samples in the subset were more than 99% similar. The final values for
the parameters (Ne =8824, μ=0.000492) were computed as a weighted mean, according to
chromosome length. These parameter values were used in conjunction with a uniform
recombination map, to infer linkage information. We painted the chromosomes of each
sample by running Chromopainter for 40 E-M iterations, maximizing over copying
proportions, with the restriction that only individuals from KH1, KH2, KH3 and KH4 were
considered as donors (i.e. KHA was assumed to be an admixture population). The plots were
generated by assigning a colour to each founder populations (KH1=purple, KH2=blue,
KH3=red and KH4=green), with each segment being painted with the colour of the
population the donor sample belonged to.
Ancestry Analysis
We used ADMIXTURE45 (http://www.genetics.ucla.edu/software/admixture/) to estimate
ancestry of the Cambodian samples. ADMIXTURE is a high-performance program for
estimating ancestry in a model-based manner from large autosomal SNP genotype datasets.
The ADMIXTURE model assumes low linkage disequilibrium between markers (SNPs).
Accordingly, we excluded SNPs pairs that appeared to be linked, by two filtering steps.
First, we removed all SNPs with extremely low MAF (MAF <= 0.01), as these SNPs are be
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less informative towards the inference process. In a second step, we discarded SNPs
according to the observed sample correlation coefficients. Using the plink tool-set (http://
pngu.mgh.harvard.edu/~purcell/plink/), we scanned the genome with a sliding window of
size 100 SNPs, advanced in steps of 10 SNPs, and removed any SNP with correlation
coefficient ≥0.02 with any other SNP within the window. The 5484 SNPs that remained
after this filtering (available upon request) was used to run ADMIXTURE with 5-fold cross
validation, 1000 replicates for bootstrapping and K=4.
FST Estimation
To estimate the FST between two populations at a given SNP, we used
where πs is the average probability that two samples chosen at random from the same
population will carry different allele at the SNP, and πt is the average probability that two
samples chosen at random from the joint population will carry different allele. If one of the
alleles is observed with frequencies p1 and p2 in the two populations, we estimate
To estimate genome-wide FST between two populations, we used GWFST = 1 - (Πs/Πt)
where Πs is the average correspondence within the two populations, and Πt is the average
correspondence in the joint population. Given a genome-wide set of M SNPs, the above can
be expressed as
From applying the estimators for πs and πt at each of the 86,128 SNPs, we derive genome-
wide FST estimates.
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Figure 1. Population Structure in the samples set analysed
(a) Neighbour-joining (NJ) tree of all 825 samples, based on a pairwise distance matrix. The
West African (WAF) samples are very clearly separated from South-East Asian (SEA) one.
Within SEA, we observe that Thailand samples form a distinct cluster from Cambodian
samples. Even within Cambodia, we see clear separation between a NE Cambodia/Vietnam
group and a western Cambodian cluster. Sample in western Cambodia form a common
clade, in spite of discernible population structure. (b) Three-dimensional plot of Principal
components analysis (PCA) using all 825 samples, showing the first three components (PC1,
PC2 and PC3). PC1 separates between continental clusters in Africa and Asia, while PC2
and PC3 largely account for the variability in western Cambodian samples (blue circles). (c,
d) PCA plots using only SEA samples, showing (c) PC1 vs. PC2, and (d) PC2 vs. PC3. Once
African samples are removed, all first three components are driven by variability in western
Cambodia. Accordingly, we identified three “outlier” clusters in Cambodia (labelled KH2,
KH3 and KH4), whose initial composition was determined by dividing the plot into
quadrants. A “core” group (labelled KH1) is composed of north-eastern and western
Cambodian samples, which cluster close to other SEA countries. Between the core and
outlier group, several samples (labelled KHA) have intermediate PC values, suggesting
admixture.
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Figure 2. Chromosome Painting
A high-level view of chromosome painting across all 14 chromosomes is shown here. Each
line represents a sample; samples are organized by subpopulation, in the order KH1, KHA,
KH2, KH3 and KH4, starting from the bottom. The colours of segments indicate the cluster
found to be the most probable donor of each segment (purple=KH1, blue =KH2, red=KH3,
green =KH4). Callouts (a-c) show details of some important features of the painting plots.
(a) KH1 samples contain many short segments of DNA sequence labelled as KH2/3/4,
consistent with KH1 representing the ancestral population from which KH2/3/4 are derived.
(b) KH2/3/4 samples comprise very long segments labelled as belonging to other
populations, suggesting recent admixture. (c) KHA samples contain both short and long
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chunks of DNA labelled as KH2/3/4, consistent with the hypothesis that it is an admixed
population, with contribution from these ART-R subpopulations.
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Figure 3. Genetic and Phenotypic differentiation between Cambodian subpopulations
(a) Ancestry analysis of the 293 Cambodian samples, based on chromosome painting
analysis of all Cambodian samples (see Methods). In this figure, each vertical bar represents
a single samples, and the bar is coloured according to the proportion of the genome that was
determined to have originated in each of the four KH1-KH4 clusters, as defined by PCA
analysis (KH1=purple, KH2=blue, KH3=red, KH4=green). Samples were ordered according
to these proportions, and any sample with ≥80% of the genome originating from a single
cluster was assigned the label of that cluster. Any sample that was not labelled as belonging
to one of the resulting four subpopulations was assigned to the KHA group. The final
partitioning of samples into subpopulations is shown in the figure. Most of the samples
classified as KHA appear to be composed of a mixture of KH1 and one or more of the
remaining clusters, consistent with the hypothesis of a recombinant population. (b) Boxplot
showing the distribution of artemisinin response phenotypes (parasite clearance half-life) in
the Cambodian parasite subpopulations thus identified (n=212). Each box represents the
interquartile range of values, split at the median; whiskers extend to the furthest point that is
within 1.5 times the length of the box. (b) An analogous plot derived from an analysis of
Western Cambodian parasites only (i.e. excluding the Ratanakiri site; n=166). A table of
parasite clearance half-life with p-values is given in Supplementary Table 1.
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Figure 4. Evidence for multiple founder effects in Cambodian subpopulations
(a) Minor allele frequencies (MAF) spectra for 7 populations. For each population, SNPs
with MAF > 0 were assigned to one of 5 equally-sized MAF bins, and we show counts in
these bins. A sub-sampling procedure, averaged over 1000 iterations, was used to minimize
confounding by differences in sample size. MAF frequency spectra of KH1 and KHA are
consistent with the rest of SEA, with a high proportion of low-MAF SNPs. In contrast, the
ART-R subpopulations (KH2, KH3 and KH4) have considerably fewer SNPs at low
frequency, and more homogeneous frequency spectra. (b) Genome-wide decay of Linkage
Disequilibrium (LD), expressed using a classic LD measure (r2). SNPs with MAF >0.15
were organized into equal-size allele frequency bins. Each bin was analyzed independently
and corrected for effects of sample size and population structure, before bin results are
aggregated (see Supplementary Note). African populations exhibit rapid LD decay, with no
detectable LD within 1 kbp. In Cambodian ART-R subpopulations, LD decays over much
greater distances than in other groups (including KH1 and KHA), suggesting highly reduced
haplotype diversity. (c) Genome-wide distribution of haplotype homozygosity in different
populations. Each box represents the interquartile range of values, split at the median;
whiskers extend to the furthest point that is within 1.5 times the length of the box. A sliding
window of width 201 SNP was used to construct local haplotypes for each sample. While
“core” populations of South-East Asia (SEA and KH1) have a level of haplotype diversity
consistent with that seen in Africa (WAF), the ART-R subpopulations (KH2, KH3 and
KH4) exhibit much higher homozygosity, indicating reduced overall haplotype diversity.
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Table 1
Geographical origin of the 825 samples in the dataset.
Region CountryCode Country Location Sample size
West Africa
BF Burkina Faso Bobo-Dioulasso 48
GM Gambia Banjul 67
GH Ghana Navrongo 243
ML Mali Bamako 56
South-East
Asia
TH Thailand Mae Sot 106
VN Vietnam Binh Phuoc Province 12
KH
Cambodia (east) Ratanakiri 50
Cambodia (west)
Pailin 49
Tasanh 47
Pursat 147
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Table 2
Distribution of the Cambodian clusters samples (as described in the text) by geographical
locations
Counts of samples for which a clinical artemisinin phenotype was available are shown in brackets after the
counts of all samples.
Location KH1 KH2 KH3 KH4 KHA Total
Pailin 4 (1) 14 (5) 5 (3) 26 (21) 49 (30)
Tasanh 1 (1) 9 (9) 3 (3) 34 (34) 47 (47)
Pursat 10 (4) 32 (21) 15 (12) 17 (12) 73 (40) 147 (89)
Ratanakiri 48 (44) 2 (2) 50 (46)
Total 63 (50) 55 (35) 23 (18) 17 (12) 135 (97) 293 (212)
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Table 3
Artemisinin response characteristics of Cambodian populations
The columns indicate the number of samples (N), the median parasite clearance half-life (“Half-life”), and the
p-value (P) of a Mann-Whitney test comparing the half-life distribution for the subpopulation against that of
KH1. The analysis results are shown using all Cambodian samples, and also using samples from Western
Cambodia alone (Pailin, Tasanh and Pursat sites). Even compared against the smaller KH1 sample size in
Western Cambodia, clearance half-lives are significantly longer in the KH2-KH4 subpopulation and in the
KHA recombinant population.
All Cambodian samples Western Cambodian samples
N Half-life P N Half-life P
KH1 50 2.7 hrs 6 4.1 hrs
KH2 35 6.8 hrs 2 ×10−14 35 6.8 hrs 2 × 10−4
KH3 18 6.4 hrs 7 × 10−9 18 6.4 hrs 6 × 10−3
KH4 12 6.4 hrs 10−7 12 6.4 hrs 2 × 10−3
KHA 97 6.6 hrs 7 × 10−16 95 6.7 hrs 4 × 10−3
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